Roche Group

GPTKB entity

Statements (65)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:alsoKnownAs gptkb:F._Hoffmann-La_Roche_AG
gptkbp:CEO gptkb:Thomas_Schinecker
gptkbp:chairman gptkb:Christoph_Franz
gptkbp:competitor gptkb:Pfizer
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Merck_&_Co.
gptkb:Sanofi
gptkb:Novartis
GlaxoSmithKline
gptkbp:country gptkb:Switzerland
gptkbp:dividendPaying Annual
gptkbp:focusArea Neuroscience
Oncology
Immunology
Infectious diseases
Ophthalmology
gptkbp:foundedIn 1896
gptkbp:founder gptkb:Fritz_Hoffmann-La_Roche
gptkbp:headquartersLocation gptkb:Basel,_Switzerland
https://www.w3.org/2000/01/rdf-schema#label Roche Group
gptkbp:industry Pharmaceuticals
Diagnostics
gptkbp:ISIN CH0012032048
gptkbp:languageOfService gptkb:French
gptkb:German
gptkb:Italian
English
gptkbp:listedOn gptkb:SIX_Swiss_Exchange
gptkbp:logo Roche logo.svg
gptkbp:marketCap over CHF 200 billion
gptkbp:memberOf gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
gptkbp:notableAcquisition gptkb:Foundation_Medicine_(2018)
gptkb:Genentech_(2009)
Flatiron Health (2018)
Spark Therapeutics (2019)
gptkbp:numberOfEmployees over 100,000
gptkbp:parentCompany gptkb:Genentech
gptkb:Foundation_Medicine
gptkb:Chugai_Pharmaceutical
gptkb:Ventana_Medical_Systems
gptkbp:product gptkb:Actemra
gptkb:Avastin
gptkb:Herceptin
gptkb:MabThera
gptkb:Ocrevus
gptkb:Perjeta
gptkb:Rituxan
gptkb:Tamiflu
gptkb:Tecentriq
gptkb:Xeloda
gptkb:Cobas_Diagnostics
gptkbp:publiclyTraded Yes
gptkbp:rank gptkb:Fortune_Global_500
gptkbp:revenue CHF 63.3 billion (2023)
gptkbp:slogan Doing now what patients need next
gptkbp:stockExchange gptkb:SIX_Swiss_Exchange
gptkbp:stockSymbol gptkb:ROG
gptkbp:subsidiary gptkb:Genentech
gptkb:Chugai_Pharmaceutical
gptkbp:type Aktiengesellschaft (AG)
gptkbp:website https://www.roche.com/
gptkbp:bfsParent gptkb:Roche_Diagnostics
gptkbp:bfsLayer 6